Rohto Pharmaceutical Co.,Ltd.
JPX: 4527.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Hidetoshi Segi
- Employees
- 7,259
- Headquarters
- Osaka, Japan
- IPO year
- 2001
- Market cap
- ¥534.7B
- Website
- https://www.rohto.co.jp
Loading 4527…
Loading profile data…Frequently asked questions about 4527
What does Rohto Pharmaceutical Co.,Ltd. (4527.T) do?
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; m...
Where does 4527.T trade?
Rohto Pharmaceutical Co.,Ltd. (4527.T) trades on the Tokyo Stock Exchange.
What sector is 4527.T in?
Rohto Pharmaceutical Co.,Ltd. (4527.T) operates in the Consumer Defensive sector, specifically in the Household & Personal Products industry.
Who is the CEO of Rohto Pharmaceutical Co.,Ltd.?
Hidetoshi Segi is the chief executive officer of Rohto Pharmaceutical Co.,Ltd. (4527.T).
Where is Rohto Pharmaceutical Co.,Ltd. headquartered?
Rohto Pharmaceutical Co.,Ltd. is headquartered in Japan.
Does 4527.T pay a dividend?
Yes — Rohto Pharmaceutical Co.,Ltd. (4527.T) paid a trailing twelve-month dividend of JPY 44.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4527.T go public?
Rohto Pharmaceutical Co.,Ltd. (4527.T) completed its initial public offering in 2001.